• About us
• Contact

Advertisement

Organisation › Details

WeHealth by Servier (E-Health Dept. of Servier)

WeHealth by Servier is the Group’s exciting new eHealth department. Its goal is to deliver an effective response to emerging healthcare market demand for eHealth or connected health, with an approach centered on the patient. WeHealth by Servier is driven by the spirit of entrepreneurship and intends to invest in innovations created in partnership with startups worldwide. *

 

	Start	2016-06-01 established
	Group	Servier (Group)
	Industry	E-health
	Industry 2	digital health (healthcare informatics)
	Person	Guez, David (Servier 201706 Head of WeHealth by Servier)
	Region	France_oo
	Country	France
	City	n. a.
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Servier. (8/24/17). "Press Release: WeHealth by Servier, Servier’s E-health Department, Teams Up with CardioRenal to Provide Better Support to Heart Failure Patients".
		Record changed: 2024-02-12

Advertisement

More documents for Servier (Group)

• [1] Owkin. (10/17/23). "Press Release: Servier Partners with Owkin with the Aim of Discovering and Developing AI-driven Precision Therapeutics"....
• [2] Aqemia SAS. (1/9/23). "Press Release: Servier and Aqemia Extend Collaboration on Undruggable Target in Immuno-Oncology". Paris....
• [3] Aqemia SAS. (12/16/21). "Press Release: Aqemia and Servier Announce AI and Quantum Physics-drive Drug Discovery Collaboration in Immuno-oncology". Paris....
• [4] Servier. (6/16/21). "Press Release: Servier and PRISM BioLab Enter Drug Discovery Collaboration for a Novel Target". Paris & Tokyo....
• [5] MiNA Therapeutics Ltd.. (1/21/21). "Press Release: Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases". Paris & London....
• [6] Cytokinetics, Inc.. (12/23/20). "Press Release: Cytokinetics Regains European Rights to Omecamtiv Mecarbil". South San Francisco, CA....
• [7] Servier. (12/21/20). "Press Release: Servier to Acquire Agios Pharmaceuticals’ Oncology Business". Paris & Boston, MA....
• [8] Cytokinetics, Inc.. (11/23/20). "Press Release: Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 from Amgen". South San Francisco, CA....
• [9] Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris....
• [10] Servier. (10/6/20). "Press Release: The Servier Group Accelerates Its Digital Transformation and Has Named Virginie Dominguez as Chief Digital Officer". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.